Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic ...

FDA sets PDUFA Action Date of June 28, 2025 ...

Neurizon has been buoyed by the receipt of a positive opinion from the European Medicines Agency in relation to its ...

MPs will soon vote on whether the terminally ill can end their lives. The decision is fraught with logistical and ethical questions ...

In May 2024, Zai Lab announced that the Centre for Drug Evaluation (CDE) accepted the sBLA with priority review designation for VYVGART Hytrulo for CIDP in China. The CDE granted the Breakthrough ...

Zai Lab Limited and argenx (Euronext & Nasdaq: ARGX) today announced that China's National Medical Products Administration (NMPA) approved the supplemental Biologics License Application (sBLA) for ...

Children were given electroconvulsive therapy and sedatives as punishment - and it wasn't limited to Lake Alice.

Please note some users may not behave properly and may post content that ... design the optimal drug composition with the desired characteristics for treating autoimmune diseases. The Company will in ...

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...

Mind Medicine’s share price has responded very strongly to Q3 update that contained very little new information. Read why I ...

Memorandum of Understanding has been signed NEW YORK, Nov. 11, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc ...

Hoag Memorial Hospital Presbyterian, one of Orange County’s largest hospitals, has implemented the latest in liver cancer ...